MONIQUE MEDINA: Open Payments
NPI 1467967240 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 60 payments from 19 companies in 2025. Trend: 2023 $1,558 · 2024 $1,474 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $221 |
| Novo Nordisk Inc | 10 | $172 |
| Astellas Pharma US Inc | 3 | $99 |
| Lilly USA, LLC | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Radius Health, Inc. | 3 | $81 |
| Exact Sciences Corporation | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| PFIZER INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: TRELEGY ELLIPTA, REXULTI, Ozempic, Veozah, JARDIANCE, Wegovy, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
